{"id":"https://genegraph.clinicalgenome.org/r/30c9630b-1686-4247-ae5d-b1f11e5ff474v1.0","type":"EvidenceStrengthAssertion","dc:description":"*STEAP3*, also called *TSAP6*, was first reported in relation to autosomal dominant severe congenital hypochromic anemia with ringed sideroblasts in 2011 (Grandchamp B et al., PMID:22031863). The index family from the original report presented with transfusion-dependent, poorly regenerative anemia and iron overload with onset in early childhood asserted to be caused by a premature termination in *STEAP3* (p.Cys110Ter); the affected siblings also inherited a lowly expressed hypomorphic allele. In a 2015 report by Liu et al. (PMID:26675350) 33 heterozygotes carrying an early termination variant (p.Cys271Ter) were identified and none of them had any significant erythrocyte hematologic phenotype. This report also includes a family where the mother has a missense *STEAP3* variant and no phenotype, the father has a missense variant predicted to be a null variant after transfection in HeLa cells showed completely abrogated iron reduction but has no hematologic phenotype and the coupleâ€™s child carries both variants in a compound heterozygous state and has no hematologic phenotype.\n\n\nThis gene-disease relationship is supported by expression studies, biochemical function assays and animal models. RNA-seq performed on 27 tissues from 95 individuals shows specific expression of *STEAP3* in the liver (PMID:24309898). Overexpression of *STEAP3* by plasmids in HEK-293T cells showed the ferrireductase activity of *STEAP3* (PMID:16609065). Lespagnol A et al. created a *TSAP6* knockdown mouse model where the mice presented with microcytic, hypochromic anemia (PMID:18617898). A mouse model (nm1054) known to have microcytic, hypochromic anemia was investigated and found to have *STEAP3* through a positional cloning approach. Ferrireductase activity was measured in reticulocytes harvested from the mice. Both mutant and null cells were both found to have reduced activity as compared to the wild-type (PMID:16227996).\n\nIn summary, the evidence supporting the relationship between STEAP3 and autosomal dominant severe congenital hypochromic anemia has been disputed and no valid evidence remains to support the claim. More evidence is needed to either support or entirely refute the role *STEAP3* plays in this disease. This classification was approved by the ClinGen General Inborn Errors of Metabolism GCEP on the meeting date 25 April, 2025 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/30c9630b-1686-4247-ae5d-b1f11e5ff474","GCISnapshot":"https://genegraph.clinicalgenome.org/r/81153e33-d848-4657-92d0-0c09ea4254ac","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/81153e33-d848-4657-92d0-0c09ea4254ac_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10097","date":"2025-06-06T15:36:07.080Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/81153e33-d848-4657-92d0-0c09ea4254ac_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10097","date":"2025-04-25T19:00:00.000Z","role":"Approver"}],"curationReasonDescription":"Several individuals are reported in one publication (PMID:26675350) carrying a deleterious variant in this gene in the heterozygous state with no significant erythrocyte hematologic phenotype. This same report has a family with heterozygote parents and a compound heterozygote child with no hematologic phenotype. ","curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81153e33-d848-4657-92d0-0c09ea4254ac_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81153e33-d848-4657-92d0-0c09ea4254ac_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b189190-e225-42d6-ba38-75680ab46f67","type":"EvidenceLine","dc:description":"Score reduced as a mouse model of similar evidence has already been scored. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28af7781-a9d4-4ba7-a684-cfe31f61d1a1","type":"Finding","dc:description":"The human family reported has the same type of anemia as found in the mouse. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18617898","rdfs:label":"Lespagnol Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/034371e7-5099-458f-a1c7-60451e19d7c6","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9550e87f-8219-40b8-81fa-40ee0c2a65cd","type":"Finding","dc:description":"The mouse cell phenotype relates to the human phenotype because a deficiency in ferrireductase activity leads to a build up of iron and the reported family has hypochromic microcytic anemia, which is also observed in the mouse, due to a low amount of hemoglobin, possibly due to the lack of iron availabble to make it. The mouse phenotype is also hypochromic microcytic anemia.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16227996","rdfs:label":"Ohgam Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/81153e33-d848-4657-92d0-0c09ea4254ac_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/afa5d82c-296e-4933-acff-6d0e616c8b3a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef8b0fd8-43aa-4e37-b491-b4bc5d76f26a","type":"Finding","dc:description":"Dysfunction in or disruption to the conversion of insoluble ferric to a soluble ferrous form results in a build up of iron inside cells which reduces its availability for hemoglobin. This explains the low concentration of hemoglobin in the erythrocytes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16609065","rdfs:label":"Ohgami Biochemical Function (ferrireductase)","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/cbbb35a6-028a-4f80-8deb-37d516678226","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/573565c7-e8c1-4f5c-b6ee-0a482dd5dd79","type":"Finding","dc:description":"RNA-seq samples from 95 different individuals showed that STEAP3 has significantly higher expression in the liver than anywhere else. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24309898","rdfs:label":"Fagerberg Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/81153e33-d848-4657-92d0-0c09ea4254ac_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67f83e08-94ae-48a2-9eb8-08c365b38e66","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67f83e08-94ae-48a2-9eb8-08c365b38e66_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Immunoprecipitation followed by Western blot analysis of the STEAP3/TSAP6 protein using anti-mSTEAP3/TSAP6 antibodies showed severely reduced STEAP3 in B-lymphocytes from the patient","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/67f83e08-94ae-48a2-9eb8-08c365b38e66_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22031863","allele":{"id":"https://genegraph.clinicalgenome.org/r/4405af1e-44d1-4f76-8b38-13473d66c1ec","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_182915.3(STEAP3):c.330C>A (p.Cys110Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA214416"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4efc150b-993f-4a45-97ee-e497e4ef8cf2","type":"EvidenceLine","dc:description":"This proband has no hematologic phenotype. ","calculatedScore":0.1,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4efc150b-993f-4a45-97ee-e497e4ef8cf2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26675350","allele":{"id":"https://genegraph.clinicalgenome.org/r/a6569d39-6c45-41f9-b00b-afb474559121","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_182915.3(STEAP3):c.976C>A (p.His326Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1846757"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4c92741d-61ca-4dea-9a6c-bafd9fa95766","type":"EvidenceLine","dc:description":"This proband has no hematologic phenotype despite the low mRNA expression.","calculatedScore":0.5,"direction":"Contradicts","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c92741d-61ca-4dea-9a6c-bafd9fa95766_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Relatively reduced STEAP mRNA expression in the proband carrying two variants and the father carrying onnly this variant. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4c92741d-61ca-4dea-9a6c-bafd9fa95766_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26675350","allele":{"id":"https://genegraph.clinicalgenome.org/r/00ba1567-9b34-44aa-a5c3-79a9c5296d5a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_182915.3(STEAP3):c.899G>A (p.Arg300His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1846734"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/81153e33-d848-4657-92d0-0c09ea4254ac_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39ce9afc-3c25-46b6-90a0-20ba3c3dbd2a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22031863","rdfs:label":"Grandchamp Index Family ","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/39ce9afc-3c25-46b6-90a0-20ba3c3dbd2a","type":"Family","rdfs:label":"Grandchamp Index Family ","member":{"id":"https://genegraph.clinicalgenome.org/r/0a0b3213-361d-4d78-9301-27c37cbb856c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22031863","rdfs:label":"Grandchamp Index Family Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":26,"allele":{"id":"https://genegraph.clinicalgenome.org/r/4405af1e-44d1-4f76-8b38-13473d66c1ec"},"detectionMethod":"Analysis of cDNA was also performed on reverse transcribed mRNA","firstTestingMethod":"PCR","previousTesting":true,"previousTestingDescription":"The authors sequenced the following candidate genes: ALAS2, DMT1, SLC25A37, SLC25A38, SEC15L1, STEAP3/TSAP6, STEAP4\n","secondTestingMethod":"Other","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/67f83e08-94ae-48a2-9eb8-08c365b38e66_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/0a0b3213-361d-4d78-9301-27c37cbb856c"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Disputed","sequence":10543,"specifiedBy":"GeneValidityCriteria11","strengthScore":6,"subject":{"id":"https://genegraph.clinicalgenome.org/r/imjN4MUKzag","type":"GeneValidityProposition","disease":"obo:MONDO_0014094","gene":"hgnc:24592","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_81153e33-d848-4657-92d0-0c09ea4254ac-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}